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Abstract
Background: Individualbased measures for comorbidity are of increasing importance for planning
and funding health care services. No measurement for individualbased healthcare costs exist in
Sweden. The aim of this study was to validate the Johns Hopkins ACG Case-Mix System's
predictive value of polypharmacy (regular use of 4 or more prescription medicines) used as a proxy
for health care costs in an elderly population and to study if the prediction could be improved by
adding variables from a population based study i.e. level of education, functional status indicators
and health perception.
Methods: The Johns Hopkins ACG Case-Mix System was applied to primary health care diagnoses
of 1402 participants (60–96 years) in a cross-sectional community based study in Karlskrona,
Sweden (the Swedish National study on Ageing and Care) during a period of two years before they
took part in the study. The predictive value of the Johns Hopkins ACG Case-Mix System was
modeled against the regular use of 4 or more prescription medicines, also using age, sex, level of
education, instrumental activity of daily living- and measures of health perception as covariates.
Results: In an exploratory biplot analysis the Johns Hopkins ACG Case-Mix System, was shown
to explain a large part of the variance for regular use of 4 or more prescription medicines. The
sensitivity of the prediction was 31.9%, whereas the specificity was 88.5%, when the Johns Hopkins
ACG Case-Mix System was adjusted for age. By adding covariates to the model the sensitivity was
increased to 46.3%, with a specificity of 90.1%. This increased the number of correctly classified by
5.6% and the area under the curve by 11.1%.
Conclusion: The Johns Hopkins ACG Case-Mix System is an important factor in measuring
comorbidity, however it does not reflect an individual's capability to function despite a disease
burden, which has importance for prediction of comorbidity. In this study we have shown that
information on such factors, which can be obtained from short questionnaires increases the
probability to correctly predict an individual's use of resources, such as medications.
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Background
During the 20th century there has been a dramatic change
in demography of the western world, with an increasing
elderly population. The group of elderly >80 years is now
the fastest growing segment of the population [1]. With
increasing age, there is an increased risk of having one or
more chronic diseases [2,3]. People with multiple chronic
conditions take up a large part of the healthcare resources
[4]. Significant progress has been made in the develop-
ment of therapies, disease management and patient edu-
cation, but with rare exceptions they have been focused on
single chronic conditions [5]. In Sweden where the
healthcare system has centered around hospital care, there
has recently been a change in policy with an increasing
lean towards primary health care to provide health care
for the elderly population. Today it is not possible from
routine health care statistics to get an overall picture of
care provided to patients with multiple chronic condi-
tions. In the Swedish healthcare system, which has
become increasingly specialised this patient group is
dependent on several different caregivers who often have
limited communication and consensus in planning for
management of clinical care. This has resulted in a
clouded picture, where the need of the patient could be
unevenly distributed between different needs or fall
between providers, due to lack of coordination and
knowledge of the individuals overall needs. It has become
increasingly important to establish a system to find and
characterise patients with multiple chronic conditions as
a growing body of research suggests that coordinated care
(case management) results in better outcomes at lower
costs [6]. The Johns Hopkins Case-Mix system [7] uses the
individual as the unit of analysis for clinical and popula-
tion purposes, which scores the degree of comorbidity
from diagnoses during a time period, obtained from elec-
tronic patient records. Our hypothesis was that a measure-
ment of comorbidity must take into account not just
burden of chronic conditions, but also other aspects that
may be of importance in characterising an individual's
comorbidity such as the individual's age, sex, level of edu-
cation, functional status indicators, health perception and
attitudes towards future health.
Polypharmacy [8,9] is associated with treatment of multi-
ple chronic conditions and represents the patient's doc-
tor(s) assessment of the patients overall burden of disease.
In the elderly it also represents a significant part of the cost
for care. Since individual costs for care is not available in
Sweden, as is the case also in many European countries
because the funding is provided at the population level
through national taxation, polypharmacy was chosen as a
proxy measurement of care provided with which comor-
bidity was compared using the Johns Hopkins ACG Case-
Mix system.
The aim of the study was to validate the Johns Hopkins
ACG Case-Mix System in Swedish primary health care and
to study if additional individual based data i.e. age, sex,
level of education, activity of daily living (ADL), instru-
mental activity of daily living (IADL) and health percep-
tion, obtained from questionnaries in a population study,
could improve the prediction.
Methods
Study population
The Swedish National study on Ageing and Care (SNAC)
is a populationbased-, multicenter-, cohort study, which
started enrollment of subjects in 2001. The study has four
participating centers. One of the centers is SNAC-Blekinge
which encompasses the Karlskrona community situated
in south-eastern Sweden with 60600 inhabitants. This
study includes baseline data collected between April 2001
and May 2003. A random, age stratified sample was
selected from the population registry among those aged
60, 66, 72, 78, and 81 years. Among those aged 84, 87, 90,
93, and 96 years the entire population was included.
Details of the study has been described earlier [1].
Approval was obtained from the Research Ethical Com-
mittee at Lund University, Sweden. Informed consent was
obtained from all participants.
Dependent variable
Drug use
Data on drug use were obtained from the participant
interview. The participants were also asked to show con-
tainers, prescriptions and medication lists. If the partici-
pant was unable to give information, it was obtained from
a relative, caregiver, medical staff or from prescription lists
for those using the APODOS (Swedish Pharmacy Inc.)
drug dispensing system. Drug use was defined as the use
of drugs on a regular basis at the time of the interview and
as needed at any time during the preceding month. Alter-
native medicines and over-the-counter drugs were also
registered, but were not used in the analyses. Drugs were
classified according to the Anatomical, Therapeutic and
Chemical (ATC) classification system as recommended by
the WHO [10]. In Sweden funding of healthcare is done
at the population level. No information exist on health
care cost exist on an individual level. Use of prescribed
drugs represents a substantive part of the care for elderly
and represents the patients doctor(s) assessment of the
patients overall burden of disease. Polypharmacy was
defined as the regular use of four or more prescription
medicines. The dependent variable was dichotomized 1
(regular use of four or more prescription medicines) or 0
(regular use of less than four prescription medicines).BMC Public Health 2006, 6:171 http://www.biomedcentral.com/1471-2458/6/171
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Independent variable
Comorbidity
The Johns Hopkins ACG Case-Mix System is based on the
theory that comorbidity, measured as a sum of diagnoses
from a time period using special algorithms for grouping
corresponds to a certain need for health care resources.
Information about the Johns Hopkins ACG Case-Mix Sys-
tem, when used in Swedish primary health care and the
grouping algorithms has been published earlier [11,12].
Briefly, the end result of the grouping is that each patient
is allotted to one of 82 ACG groups, depending on his/her
types of morbidity that are characterized using five criteria
1. Likely persistence of the condition 2. Severity of the
condition 3. Aetiology 4. Diagnostic certainty and 5. Need
for speciality care. Thus each ACG describes patients with
the same type and degree of comorbidity. Diagnoses were
obtained from electronic patient records of the three pri-
mary care districts in Karlskrona community of the partic-
ipants and the ACG Case-Mix system 6.0 was applied to
the diagnoses in a period of up to two years before they
participated in the baseline study of SNAC-Blekinge. For
analysis purposes the ACGs were collapsed into six catego-
ries (0–5) of resource utilisation bands (RUB), a higher
number indicating higher morbidity. The RUB for each
participant was obtained from the output of the ACG soft-
ware, where 0 indicated no need for primary health care
resources and 5 very high need for primary health care
resources [7].
Covariables
The research data was obtained from questionnaire's, that
were part of the SNAC-Blekinge study. The scales used in
this study were analysed to assess their reliability using the
raw item scores. Using the 'alpha' command which analy-
ses all items of a scale and in addition to calculating Cron-
bach's  α [13] generates a standardised summative
measure (mean 0 and standard deviation 1) of each scale
into a new variable. If necessary the 'alpha' command
automatically reverse the items of the scales. Thus a new
composite variable was made from each scale and was
used as covariates in the analysis.
Gender
Age when the individual participated in the baseline
study.
Level of education: the highest educational level of each
participant was registered and categorised in the following
categories; incomplete public school, 6 years of public
school, 9 years of public school, complete college educa-
tion, college education plus one year of post college edu-
cation, complete university degree, complete PhD degree.
Activity of daily living (ADL) consisted of the following
items: movement indoors, toilet, mobility from bed to
chair, dressing/undressing, continence, eating [14].
Instrumental activity of daily living (IADL) consisted of
the following items: cooking, laundry, use of public trans-
portation, bathing, shopping for food, household shores,
mobility outdoors [15].
Depression was measured through the Montgomery
Åsberg Depression Rating Scale inventory [16]. The
MADRS was specifically constructed for measuring
depression and be sensitive to treatment effects. It
includes 10 items and its range is between 0–60. In the
present study 9 of the 10 items were used, hence yielding
a range from 0–54. The MADRS has previously demon-
strated to be a robust and valid measure of depression
[17].
For studying self-estimated health a questionnaire (SCB)
developed by Statistics Sweden for use in: Surveys of Liv-
ing Conditions in Sweden (ULF) was used [18].
Attitudes towards future health was determined using part
of a larger questionnaire on different aspects of health per-
ception developed and validated by Ware et al [19].
Statistical analysis
Independent variables to be included in a model were
explored using biplots [20], where the variance explained
by the variable is proportional to the length of the lines
and the correlation between different independent varia-
bles is proportional to the cosine of the angle between the
lines. Logistic regression was used to fit a model with
polypharmacy, as the dependent variable and RUB as the
independent variable. Sample weights were used to adjust
for disproportionate sampling between the age groups.
The model was adjusted for age (model A), age and sex
(model B) age, sex, level of education and IADL (model
C), age, sex, level of education, IADL, SCB and Ware
(model D) in consecutive steps. Odds ratios for polyphar-
macy at different levels of RUB were calculated for each
model. To evaluate the importance of RUB for predicting
the outcome a model E consisting of model D but exclud-
ing RUB was made. The performance of model A-E for dis-
criminating users and nonusers of polypharmacy was
assessed and compared with receiver operating character-
istic analysis (ROC). To assess the predictive capacity of
the model, we calculated the concordance rate between
predicted and observed responses and used the Hosmer-
Lemeshow goodness-of-fit test [21]. All analyses were
done using statistical package Stata version 9.1 (Stata Cor-
poration, Texas, USA).BMC Public Health 2006, 6:171 http://www.biomedcentral.com/1471-2458/6/171
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Results
A total of 2312 individuals were invited to participate in
the study. In total, 1402 (60.5%) of those invited agreed
to participate. Of these 41.7% were men and 58.3%
women. The participation rate was 75.2%, 66.3%, 53.7%
and 47.0% for the age groups 60–69, 70–79, 80–89 and
90-years respectively. The proportion of participants in
the study with different needs of primary health care and
use of polypharmacy is shown in table 1. Of the partici-
pants 1381 had given information on their use of pre-
scription drugs and a further 237 had missing values on
the independent variables, table 2. This left 1144 partici-
pants with complete datasets, who participated in this
study.
The biplot analysis showed that ADL was highly corre-
lated with IADL and MADRS to age. Due to risk of prob-
lems with multicollinearity these variables were omitted
from the models. The odds ratio for having polypharmacy
was significantly increased in RUB 3 and 4, when com-
pared with RUB 0, table 3. The number of participants in
RUB 5 were small and the confidence intervall large. How-
ever in model A-C, those in RUB 5 had a higher need for
polypharmacy. In further analysis the ability of the Johns
Hopkins ACG Case-Mix system to discriminate between
users and nonusers of polypharmacy and if it could be
improved was tested by adding independent variables to
the model in subsequent steps, table 4. The univariate
model is not presented as missingness of data was age
dependent and could violate missing data assumptions.
By adding independent variables to the model the sensi-
tivity rose by 14.4%, with a 1.6% decline in specificity.
The number of correctly classified rose by 5.6% and the
area under the curve by 11.1%. Using ROC analysis model
D was shown to have a significantly better discriminatory
power when tested against models A-C (p < 0.001) or
model E (p < 0.001), where RUB had been excluded. The
predictive models that included RUB all had a good fit,
whereas model E provided a poor fit.
Discussion
In this study we have shown that the Johns Hopkins ACG
Case-Mix system is a major factor in the model explaining
the proxy variable polypharmacy. We have also shown
that the sensitivity of the Johns Hopkins ACG Case-Mix,
when used with Swedish primary health care diagnoses
could be improved. This finding is not surprising since
primary health care diagnoses provide little information
on the severity of the diagnosis, the individuals ability to
function despite a disease burden, the patient's health per-
ception or his/her attitudes towards future health. By add-
ing information on the biologic severity of the diagnoses
in subsequent steps, the individual's age, sex, level of edu-
cation, functional status indicators and healthperception,
we were both able to improve the sensitivity and discrim-
inatory power of the prediciton of the proxy variable poly-
pharmacy. Only models that included RUB provided a
good fit. We especially found that information on an indi-
vidual's IADL function and self estimated health comple-
ment the information given by the Johns Hopkins ACG
Case-Mix together with age and gender on the level of the
individual's comorbidity.
Table 1: Proportion of population with a specific degree of 
utilisation of primary health care and polypharmacy by age and 
gender.
Age (years) RUBa 60–69
n = 206
%
70–79
n = 192
%
80–89
n = 318
%
90–96
n = 88
%
Female 0 59.7 21.9 19.2 36.4
1 3.4 4.2 8.2 11.4
2 15.0 21.3 19.8 17.0
3 18.4 46.9 45.3 28.4
4 3.4 5.7 6.3 6.8
5 0 0 1.3 0
Polypharmacy (%)b 19.4 34.4 50.3 58.0
Age (years) RUB 60–69
n = 186
%
70–79
n = 148
%
80–89
n = 207
%
90–96
n = 36
%
Male 0 64.5 21.6 23.7 22.2
1 2.1 6.8 7.3 5.6
2 14.5 25.7 23.7 16.7
3 17.2 38.5 39.6 47.2
4 1.6 6.1 4.8 8.3
5 0 1.4 1.0 0
Polypharmacy (%) 14.5 29.7 39.1 61.1
a Resource utilisation band (RUB) according to the Johns Hopkins 
Case-mix system.
b Polypharmacy: regular use of four or more prescribed medications.
Table 2: Prevalence of missing values in independent variables.
Age (years) 60–69
%
70–79
%
80–89
%
90–96
%
Female
Level of education 1.9 4.2 13.1 21.1
IADL function 0.5 0 1.0 0
SCB 2.4 4.7 16.5 37.6
Ware 2.4 6.3 20.2 43.1
Male
Level of education 3.3 5.4 11.0 21.4
IADL function 0 0.7 0.5 0
SCB 3.2 6.1 13.0 38.1
Ware 4.8 8.1 15.0 40.5BMC Public Health 2006, 6:171 http://www.biomedcentral.com/1471-2458/6/171
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The data for this study was derived from a population
based study and a database of diagnoses from the elec-
tronic patient record system in primary health care. The
participation rate in the population study were lower in
the older age groups and many of these non participants
voluntarily reported that they were either to old or sick to
participate, which is likely to have led to an underestima-
tion of comorbidity in the oldest age group. Also missing
values in independent variables of the self-administered
questionnaires increased with age. The diagnoses used in
this study was obtained from registers used in routine
medical care, without any additional training given to the
primary health care physicians. It is important to know
that the Johns Hopkins ACG Case-Mix system is sensitive
towards number of diagnoses used per visit and that diag-
nostic labelling by different physicians has been shown to
vary [22]. In addition there are two private primary care
physicians in the area, whose diagnostic registers were
unavailable for us, which thus would have lowered the
total comorbidity to a small degree. The diagnoses that we
used for calculations by the Johns Hopkins ACG Case-Mix
system were collected up to two years prior to their day of
participation, which has been suggested to be optimal for
the Swedish primary health care system where all chronic
conditions are not registered each year [23].
A previous Swedish study has shown that the Johns Hop-
kins ACG Case-Mix explain more of the variation in
health care cost than age and gender alone [24]. This study
has shown that the prediction of comorbidity can be
improved by adding information on functional status
indicators which is in agreement with Mayo et al. [25] and
that it can be further improved by adding selfestimated
health. The variance in health care cost explained by the
Johns Hopkins ACG Case-Mix system in a Canadian and
Spanish study was larger than in a Swedish study, which
might be due to differences in reimbursement system and
diagnostic practice [26,27].
There is a need for an individualbased measure of comor-
bidity both for funding of medical care and for planning
of preventive- and medical services. Such a measure
Table 3: Odds ratios (OR) and 95% confidence intervals (CI) for use of polypharmacy (4 or more regular prescription medicines) 
according to resource utilisation band (RUB).
RUB OR model A
95%CI
n = 1144
OR model B
95%CI
n = 1144
OR model C
95%CI
n = 1144
OR model D
95%CI
n = 1144
0 1.0 1.0 1.0 1.0
1 0.9 0.4–1.8 0.9 0.4–1.7 0.9 0.5–1.9 1.0 0.5–2.1
2 1.2 0.8–1.9 1.2 0.8–1.9 1.3 0.8–2.1 1.3 0.8–2.1
3 3.0*** 2.1–4.4 3.0*** 2.0–4.4 3.3*** 2.2–4.9 3.0*** 2.0–4.6
4 6.8*** 3.5–13.5 6.7*** 3.4–13.2 8.2*** 4.0–16.8 6.5*** 3.1–13.6
5 6.4* 1.2–35.2 7.0* 1.2–39.6 7.8* 1.5–41.0 4.8 1.1–21.3
* significant at 5%, ** significant at 1%, *** significant at 0.1%
model A: adjusted for age
model B: adjusted for age and sex
model C: adjusted for age, sex, level of education and IADL function
model D: adjusted for age, sex, level of education, IADL function, SCB and Ware
Table 4: Sensitivity, specificity, positive- and negative predicitive value (%) for detecting use of polypharmacy (4 or more regular 
prescription medicines) according to resource utilisation band (RUB).
model A model B model C model D model E
Sensitivity 31.9 33.6 38.4 46.3 41.2
Specificity 88.5 89.2 89.8 90.1 90.2
Positive predicitive value 55.4 58.3 62.7 67.8 65.5
Negative predicitive value 74.4 75.0 76.5 78.9 77.4
Correctly classified 71.0 72.0 73.9 76.6 75.1
Area under ROC curve 0.72 (0.69–0.75)a 0.73 (0.70–0.76) 0.76 (0.73–0.79) 0.80 (0.77–0.82) 0.77 (0.74–0.80)
Goodness-of-fit 0.90 0.39 0.64 0.31 0.01
a 95% confidence interval
model A: adjusted for age
model B: adjusted for sex and age
model C: adjusted for sex, age, level of education and IADL function
model D: adjusted for sex, age, level of education, IADL function, SCB and Ware
model E: model D excluding RUBBMC Public Health 2006, 6:171 http://www.biomedcentral.com/1471-2458/6/171
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should have as high validity as possible and be easy to use
in practical care. The Johns Hopkins ACG Case-Mix sys-
tem provides such a system, which has been extensively
validated both in the USA, Canada and in Europe [28-30].
Our study show that other measures complement the
information derived from this diagnosis based system in
the prediction of comorbidity. In practical care it may also
be of importance to have a comorbidity measure, which is
derived from different sources so as to minimise the effect
of different diagnostic practices by different doctors and
so called 'diagnostic gliding'.
Comorbidity provides new challenges to health care serv-
ices that have traditionally been focused on individual
diseases and with little substantial collaboration between
primary care physicians and other specialist physicians.
During the last century demography has changed radically
with moderate changes in the health care system. One of
the challenges resulting from the successes of both pre-
ventive measures, better food and curative health services
is the increase in the extent of comorbidity. Many elderly
patients now receive health care services from many dif-
ferent caregivers with little substantial collaboration.
Some forms of patient-oriented case management are spe-
cifically designed to enhance the coordination of care on
the grounds that the common characteristics of successful
care for major chronic diseases as well as for preventive
activities provide strong arguments for care to be coordi-
nated by primary care phycicians [31]. These primary care
physicians however need to have the tools that easily
identify patients with comorbidity. Use of the Johns Hop-
kins ACG Case-Mix system together with a geographical
information system provides an interesting idea to visual-
ise comorbidity [32].
Traditionally treatment programs have been focused on
individual diseases, whereas in reality 50% of all individ-
uals with chronic conditions have multiple chronic condi-
tions [33]. Individuals with multiple chronic conditions
have clinical needs that may differentiate them from per-
sons with a single chronic condition. Evidence indicates
that chronic conditions cluster and that persons with mul-
tiple chronic conditions may have more rapid declines in
health status and a greater likelihood of disability. Use of
a valid measure of comorbidity and especially if it also
could be a measure of different aspects of comorbidity
that could be demonstrated on different axis in a star dia-
gram could be of value in guiding the out patient clinician
and discharging doctor to appropriate treatment pro-
grams. Relatively recently a treatment program not
directed to a specific disease has been shown to improve
health status and reduce hospitalisation [34].
The results of this study would have been improved with
diagnostic training of the primary care physicians in the
study, although we believe it unlikely that the variation
due to this can be totally eliminated, which is why we sug-
gest this comorbidity measure based on additional differ-
ent factors. Work on establishing Patient-level Clinical
[35] costing in primary health care is currently ongoing in
Blekinge county and further work will be directed at stud-
ying if this measure holds in other clinical settings.
Conclusion
This study was done to validate the Johns Hopkins Case-
mix system in Swedish primary health care and to study if
additional information from short questionnaires could
increase the information of the individual's comorbidity
compared to that estimated by the Johns Hopkins Case-
mix system alone. In this study we have shown that infor-
mation on these factors, increases the probability to cor-
rectly predict an individual's comorbidity. This increased
the number of correctly classified by 5.6% and the area
under the curve by 11.1%. Therefore we suggest that
measures of comorbidity, which with relative ease could
be obtained from a population using questionnaires,
must include different dimensions of health and func-
tioning.
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